Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Aveanna Healthcare Holdings (AVAH) EBIAT (2020 - 2026)

Aveanna Healthcare Holdings' EBIAT history spans 7 years, with the latest figure at $178.8 million for Q1 2026.

  • For Q1 2026, EBIAT rose 512.58% year-over-year to $178.8 million; the TTM value through Jan 2026 reached $225.0 million, up 2159.05%, while the annual FY2026 figure was $225.0 million, 2159.05% up from the prior year.
  • EBIAT reached $178.8 million in Q1 2026 per AVAH's latest filing, up from $14.1 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $178.8 million in Q1 2026 to a low of -$473.9 million in Q3 2022.
  • Average EBIAT over 5 years is -$38.4 million, with a median of $5.2 million recorded in 2025.
  • The largest YoY upside for EBIAT was 1062.58% in 2022 against a maximum downside of 37710.08% in 2022.
  • A 5-year view of EBIAT shows it stood at -$237.8 million in 2022, then skyrocketed by 89.18% to -$25.7 million in 2023, then soared by 213.38% to $29.2 million in 2024, then tumbled by 51.8% to $14.1 million in 2025, then surged by 1170.99% to $178.8 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's EBIAT are $178.8 million (Q1 2026), $14.1 million (Q3 2025), and $27.0 million (Q2 2025).